Your browser doesn't support javascript.
loading
Potentially actionable FGFR2 high-level amplification in thymic sebaceous carcinoma.
Porubsky, Stefan; Jessup, Peter; Kee, Damien; Sharma, Rajiv; Ochi, Ayame; Xu, Huiling; Froelich, Jens J; Nott, Louise; Scott, Clare; Awad, Raef; Moldovan, Cristina; Hardikar, Ashutosh A; Bohnenberger, Hanibal; Küffer, Stefan; Ströbel, Philipp; Marx, Alexander.
Afiliação
  • Porubsky S; Institute of Pathology, University Medical Centre Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. Stefan.porubsky@umm.de.
  • Jessup P; Department of Pathology, Royal Hobart Hospital, Hobart, Australia.
  • Kee D; Department of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Sharma R; Cancer and Stem Cell Division, Walter and Eliza Hall Medical Research Institute, Parkville, Victoria, Australia.
  • Ochi A; Department of Cardiothoracic Surgery, Royal Hobart Hospital, Hobart, Australia.
  • Xu H; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
  • Froelich JJ; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Nott L; Department of Medical Imaging, Interventional and Neurointerventional Services, Royal Hobart Hospital, Hobart, Australia.
  • Scott C; Department of Medical Oncology, Royal Hobart Hospital, Hobart, Australia.
  • Awad R; Department of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Moldovan C; Cancer and Stem Cell Division, Walter and Eliza Hall Medical Research Institute, Parkville, Victoria, Australia.
  • Hardikar AA; Department of Radiation Oncology, Royal Hobart Hospital, Hobart, Australia.
  • Bohnenberger H; Department of Medical Oncology, Royal Hobart Hospital, Hobart, Australia.
  • Küffer S; Department of Cardiothoracic Surgery, Royal Hobart Hospital, Hobart, Australia.
  • Ströbel P; Institute of Pathology, University Medical Center Göttingen, University of Göttingen, Göttingen, Germany.
  • Marx A; Institute of Pathology, University Medical Center Göttingen, University of Göttingen, Göttingen, Germany.
Virchows Arch ; 476(2): 323-327, 2020 Feb.
Article em En | MEDLINE | ID: mdl-31401665
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias das Glândulas Sebáceas / Neoplasias Cutâneas / Adenocarcinoma Sebáceo / Receptor Tipo 2 de Fator de Crescimento de Fibroblastos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans / Male / Middle aged Idioma: En Revista: Virchows Arch Assunto da revista: BIOLOGIA MOLECULAR / PATOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias das Glândulas Sebáceas / Neoplasias Cutâneas / Adenocarcinoma Sebáceo / Receptor Tipo 2 de Fator de Crescimento de Fibroblastos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans / Male / Middle aged Idioma: En Revista: Virchows Arch Assunto da revista: BIOLOGIA MOLECULAR / PATOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha